![]() |
|
|
|
|
|
|
Summary Information (see also Sequences/Alignments below) |
Asymmetric/Biological Unit (1, 1)
|
(no "Site" information available for 3FXE) |
(no "SS Bond" information available for 3FXE) |
(no "Cis Peptide Bond" information available for 3FXE) |
(no "SAP(SNP)/Variant" information available for 3FXE) |
(no "PROSITE Motif" information available for 3FXE) |
(no "Exon" information available for 3FXE) |
Asymmetric/Biological UnitChain A from PDB Type:PROTEIN Length:48 SCOP domains ------------------------------------------------ SCOP domains CATH domains ------------------------------------------------ CATH domains Pfam domains ------------------------------------------------ Pfam domains SAPs(SNPs) ------------------------------------------------ SAPs(SNPs) PROSITE ------------------------------------------------ PROSITE Transcript ------------------------------------------------ Transcript 3fxe A 4 QLSDEQKETILKALNDAIEKGPWDKSNFLRVIGKKLIAIRDRFLKRIG 51 13 23 33 43 Chain B from PDB Type:PROTEIN Length:56 aligned with Q5ZYC9_LEGPH | Q5ZYC9 from UniProtKB/TrEMBL Length:120 Alignment length:56 39 49 59 69 79 Q5ZYC9_LEGPH 30 TDATLGSVYSEIISPVKDCILTVAKAVSFNPGGKDNTDAVEVLTELNTKVERAALN 85 SCOP domains -------------------------------------------------------- SCOP domains CATH domains -------------------------------------------------------- CATH domains Pfam domains -------------------------------------------------------- Pfam domains SAPs(SNPs) -------------------------------------------------------- SAPs(SNPs) PROSITE -------------------------------------------------------- PROSITE Transcript -------------------------------------------------------- Transcript 3fxe B 30 TDATLGSVYSEIISPVKDCILTVAKAVSFNPGGKDNTDAVEVLTELNTKVERAAmN 85 39 49 59 69 79 | 84-MSE
|
(no "SCOP Domain" information available for 3FXE) |
(no "CATH Domain" information available for 3FXE) |
(no "Pfam Domain" information available for 3FXE) |
Asymmetric/Biological Unit(hide GO term definitions)
(no "Gene Ontology" information available for 3FXE)
|
|
|
|
|
|
|